Brain-Derived Neurotrophic Factor Increases Synaptic Protein Levels via the MAPK/Erk Signaling Pathway and Nrf2/Trx Axis Following the Transplantation of Neural Stem Cells in a Rat Model of Traumatic Brain Injury

Tao Chen,Yu Wu,Yuzi Wang,Jigao Zhu,Haiying Chu,Li Kong,Liangwei Yin,Haiying Ma

DOI: https://doi.org/10.1007/s11064-017-2340-7

IF: 4.4

2017-08-05

Neurochemical Research

Abstract:Brain-derived neurotrophic factor (BDNF) plays an important role in promoting the growth, differentiation, survival and synaptic stability of neurons. Presently, the transplantation of neural stem cells (NSCs) is known to induce neural repair to some extent after injury or disease. In this study, to investigate whether NSCs genetically modified to encode the BDNF gene (BDNF/NSCs) would further enhance synaptogenesis, BDNF/NSCs or naive NSCs were directly engrafted into lesions in a rat model of traumatic brain injury (TBI). Immunohistochemistry, western blotting and RT-PCR were performed to detect synaptic proteins, BDNF-TrkB and its downstream signaling pathways, at 1, 2, 3 or 4 weeks after transplantation. Our results showed that BDNF significantly increased the expression levels of the TrkB receptor gene and the phosphorylation of the TrkB protein in the lesions. The expression levels of Ras, phosphorylated Erk1/2 and postsynaptic density protein-95 were elevated in the BDNF/NSCs-transplanted groups compared with those in the NSCs-transplanted groups throughout the experimental period. Moreover, the nuclear factor (erythroid-derived 2)-like 2/Thioredoxin (Nrf2/Trx) axis, which is a specific therapeutic target for the treatment of injury or cell death, was upregulated by BDNF overexpression. Therefore, we determined that the increased synaptic proteins level implicated in synaptogenesis might be associated with the activation of the MAPK/Erk1/2 signaling pathway and the upregulation of the antioxidant agent Trx modified by BDNF-TrkB following the BDNF/NSCs transplantation after TBI.

biochemistry & molecular biology,neurosciences

What problem does this paper attempt to address?

The problem that this paper attempts to solve is whether neural stem cells (NSCs) expressing brain - derived neurotrophic factor (BDNF) can further promote synaptogenesis after traumatic brain injury (TBI), and to explore its potential mechanisms. Specifically, the study aims to verify whether BDNF over - expression can increase the levels of synaptic proteins by activating the MAPK/Erk signaling pathway and the Nrf2/Trx axis, thereby promoting nerve repair after TBI.

The key points of the paper include:
1. **Research background**: TBI can cause brain tissue damage and trigger a series of secondary damages, such as excitotoxicity, inflammation, ischemia and oxidative stress. Neural stem cells (NSCs) have become a potential method for treating TBI because of their differentiation potential and neuroprotective effects.
2. **Research purpose**: By transplanting NSCs expressing the BDNF gene, explore its influence on the synaptic protein levels after TBI and its mechanisms.
3. **Experimental design**: In the TBI rat model, transplant NSCs expressing BDNF and unmodified NSCs respectively, and detect the changes of synaptic proteins, BDNF - TrkB and its downstream signaling pathways by immunohistochemistry, Western blot and RT - PCR techniques.
4. **Main findings**:
- BDNF over - expression significantly increased the expression of the TrkB receptor gene and protein, as well as the phosphorylation of TrkB.
- The expressions of Ras, p - Erk1/2 and PSD - 95 were significantly increased in the BDNF/NSCs transplantation group.
- The expression of the antioxidant Trx was also significantly increased.
- The Nrf2/Trx axis may promote the production of the synaptic protein PSD - 95 by inhibiting oxidative stress.

In conclusion, this study reveals that BDNF/NSCs transplantation promotes synaptogenesis and nerve repair after TBI by activating the MAPK/Erk signaling pathway and the Nrf2/Trx axis. This finding provides a theoretical basis for further developing treatment strategies for TBI.